Most patients experience brief discomfort during or immediately after injection that resolves within minutes to hours
Research shows it enhances fibroblast migration to injury sites through the FAK-paxillin pathway, improves collagen fiber organization and cross-linking, promotes angiogenesis to improve nutrient delivery, and reduces inflammatory mediators while preserving beneficial healing signals
Semaglutide, also known as Ozempic and Wegovy, is one of the leading medications for sustainable weight loss, offering meaningful results without requiring extreme diets or deprivation
The TRIUMPH-4 Phase 3 readout in April 2026 extended that to 28.7% at 68 weeks in a population with knee osteoarthritis - a patient group in whom weight loss produces disproportionate benefit on a secondary outcome (pain) the trial measured and reported as a 75.8% reduction on the WOMAC pain index
This medicines product information is available in all official EU languages
Following your doctor's guidance is essential